Which has the lower trailing P/E, DOCS or TMDX?

TMDX has the lower trailing P/E: DOCS trades at 29.11 and TMDX at 24.25. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DOCS or TMDX?

Over the past five years, TMDX grew revenue faster — DOCS at a 21.94% CAGR versus TMDX at 86.12%.

Is DOCS or TMDX more profitable?

DOCS runs the higher net margin — DOCS at 25.48% versus TMDX at 22.69%.

How have DOCS and TMDX total returns compared?

Over the past 5 years, DOCS delivered -23.11% and TMDX delivered 26.74% annualized total return. Past performance doesn't predict future results.

Doximity, Inc. (DOCS) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of Doximity, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 26, 2026. Differences are shown without an overall score or investment verdict.

DOCS

Doximity, Inc.

$4.63B

$24.74HealthcareDelayed quote: Aug 26, 2026, 4:00 PM EDT

TMDX

TransMedics Group, Inc.

$3.19B

$92.22HealthcareDelayed quote: Aug 26, 2026, 4:00 PM EDT

Total return — DOCS vs TMDX

growth of $100 · dividends reinvested · last 5y

DOCS -53.3% (-14.1%/yr)TMDX +207.7% (+25.2%/yr)TMDX compounded faster over this window

Log scale — wide-divergence pair

DOCS TMDX

DOCS vs TMDX: by the numbers

•DOCS is the larger company ($4.63B vs $3.19B market cap).
•TMDX trades at the lower trailing earnings multiple (24.25 vs 29.11 P/E), one valuation lens rather than an overall verdict.
•DOCS converts more revenue to profit (25.48% vs 22.69% net margin).
•TMDX grew revenue faster over the past five years (86.12% vs 21.94% CAGR).

Metrics side by side

Valuation

Metric	DOCS	TMDX
P/E ratio	29.11	24.25
Forward P/E	16.00	62.56
P/S ratio	7.21	5.70
P/B ratio	5.16	7.36
EV / EBITDA	21.10	35.63
FCF yield	6.33%	2.07%

Profitability

Metric	DOCS	TMDX
Gross margin	88.07%	58.69%
Operating margin	29.60%	12.21%
Net margin	25.48%	22.69%
ROE	18.24%	29.28%
ROIC	15.35%	5.87%

Growth (annualized)

Metric	DOCS	TMDX
Revenue CAGR (5Y)	21.94%	86.12%
EPS CAGR (5Y)	54.32%	N/A
FCF CAGR (5Y)	23.75%	N/A
Total return CAGR (5Y)	-23.11%	26.74%

Frequently asked

Which has the lower trailing P/E, DOCS or TMDX?: TMDX has the lower trailing P/E: DOCS trades at 29.11 and TMDX at 24.25. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DOCS or TMDX?: Over the past five years, TMDX grew revenue faster — DOCS at a 21.94% CAGR versus TMDX at 86.12%.
Is DOCS or TMDX more profitable?: DOCS runs the higher net margin — DOCS at 25.48% versus TMDX at 22.69%.
How have DOCS and TMDX total returns compared?: Over the past 5 years, DOCS delivered -23.11% and TMDX delivered 26.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DOCS analysis Full TMDX analysis Interactive comparison tool

Dig into the metrics

Doximity P/E ratio TransMedics P/E ratio Doximity ROE TransMedics ROE Doximity operating margin TransMedics operating margin Doximity revenue growth TransMedics revenue growth Doximity free cash flow TransMedics free cash flow

Doximity & TransMedics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 26, 2026.